GlassScriptPhysician profile
Robyn J Hakanson
NPI 1124012117
$4,463.40
in general payments reported to CMS, 2019-2025
10 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $206 · 2021: $450 · 2022: $1,069 · 2023: $1,027 · 2024: $649 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873 · Travel and Lodging: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,873.13 |
| Travel and Lodging | $208.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,994.97 | 2019-2025 | Mako, Triathlon, Na |
| Depuy Synthes Sales INC. | $846.53 | 2019-2025 | Monovisc, Rigidloop |
| Zimmer Biomet Holdings, INC. | $296.48 | 2024-2025 | Rosa, Persona |
| Kci USA, INC. | $105.24 | 2020 | |
| Biocomposites INC | $72.67 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $43.55 | 2023-2024 | Zilretta, Iovera, Exparel |
| Lifenet Health | $39.39 | 2025 | Theragenesis Wound Matrix |
| Globus Medical, INC. | $24.94 | 2022 | |
| Boston Scientific Corporation | $20.57 | 2024 | |
| Ferring Pharmaceuticals INC. | $19.06 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Hakanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.